cov pid 1 [ . . . . : . . . 80 1 CT153_CHLTR/1-1 100.0% 100.0% KNTVTCSTAAHSLYTLKEDD-SSNPSEKRLDSCFRNWIENKLSANSPD---SWSAFIQKFGTHYIASATFGGIGFQVLKL 2 CT153_CHLPN/1-1 100.0% 54.4% KNTVTHSTASRTLYILRQDC-SYDPRALKVDDEFRYWVEKRLDAKNPD---SLNAFVKEVGTHYVASVTYGGIGFQVLKM 3 PERF_MOUSE/1-20 92.8% 19.7% QYNFNSDTVECRMYSFRLVQ--KPPLHLDFKKALRALPRNFNSSTEH----AYHRLISSYGTHFITAVDLGGRISVLTAL 4 PERF_HUMAN/1-20 92.8% 16.1% QYSFSTDTVECRFYSFHVVH--TPPLHPDFKRALGDLPHHFNASTQP----AYLRLISNYGTHFIRAVELGGRISALTAL 5 CO6_HUMAN/1-205 92.3% 17.7% SFIRIHKVMKVLNFTTKAK---DLHLSDVFLKALNHLPLEYNSA-------LYSRIFDDFGTHYFTSGSLGGVYDLLYQF 6 CO7_HUMAN/1-202 93.3% 15.3% QLLVVENTVEVAQFINNNPE--FLQLAEPFWKELSHLPSLYDYS-------AYRRLIDQYGTHYLQSGSLGGEYRVLFYV 7 CO9_HUMAN/1-211 92.3% 15.5% MFLHVKGEIHLGRFVMRNR---DVVLTTTFVDDIKALPTTYEKG-------EYFAFLETYGTHYSSSGSLGGLYELIYVL 8 CO8A_HUMAN/1-20 92.3% 17.7% IFTRIFTKVQTAHFKMRKD---DIMLDEGMLQSLMELPDQYNYG-------MYAKFINDYGTHYITSGSMGGIYEYILVI 9 CO8B_HUMAN/1-20 92.3% 16.6% VFLHARSDLEVAHYKLKPR---SLMLHYEFLQRVKRLPLEYSYG-------EYRDLFRDFGTHYITEAVLGGIYEYTLVM 10 T22A6.120_At/1- 89.2% 16.6% TKNLAFDGVFISLYSVALD----KSQVLLREHVKQAVPSTWDPA-------ALARFIDIYGTHIIVSVKMGGKDVIYAKQ 11 MPS1_MOUSE/1-20 96.4% 14.0% QAVTTRVQVRNRIYTVKTTP--TSELSLGFTKALMDICDQLEKNQTKMATYLAELLILNYGTHVITSVDAGAALVQEDHV 12 SPOC1/1-195 93.8% 14.5% GLWSIGDLNYTVQFDMQSL---ERCINADFIWAARRLPCWDENDASAR--DAFAKFFATWGTHVTTGCCLGARYQLQVTR 13 APEX_HELER/1-21 95.9% 9.7% QTIQNFGHMRYLTSLAEHD---GFEIAREFRIDVCDLPTTYATN-------TYMEFLSKWGTSVVTEADVGVRTGINSRE 14 ASTRO_HUMAN/1-1 87.2% 12.9% YPMVQQWRVRSNLYRVKLS---TITLAAGFTNVLKILTKESSRE-------ELLSFIQHYGSHYIAEALYGSELTCIIHF 15 KIAA0289_HUMAN/ 87.2% 15.0% YPVLQHWKVRSVMYHIKLN---QVAISQALSNALHSLDGATSRA-------DFVALLDQFGNHYIQEAIYGFEESCSIWY 16 TSL_DROME/1-195 88.2% 12.4% YSYVLVRVVRFRETGRLNA---EIPVHQPLEPDVRSRMDQLQIGNIT----SAVRFMEDVGTHYVNSYTTGNSLYQVFVY 17 dJ1026E2.C1.1/1 91.3% 14.3% YREFARWKVNNLALERKDFFSLPLPLAPEFIRNIRLLGRRPNLQ------QVTENLIKKYGTHFLLSATLGGEESLTIFV 18 IB3089A_HUMAN/1 85.6% 13.5% YREFARWKVRNTAIERRDLVRHPVPLMPEFQRSIRLLGRRPTTQ------QFIDTIIKKYGTHLLISATLGGEEALTMYM consensus/100% .............................h...h..h......t........h..hh..hGsph..th.hG......... consensus/90% ........h....h.ht............h...h..h......t........h.thhtphGoHhh.ts.hGs......h. consensus/80% ...h.h.thp.h.h.hp........lt..h.pshp.lspp.p.s........h.thhppaGTHhltpsphGu.....hhh consensus/70% .hhhhptplphthaph+.....th.lt.th.pslptLspphp.s.......th.phlppaGTHalsusshGu.hthhhhh cov pid 81 . 1 . . . . : . 160 1 CT153_CHLTR/1-1 100.0% 100.0% SFEQVEDL----HSKKISLETA--------AANSLLKGSVSSS------TESGYSSYSSTSS-------------SHTVF 2 CT153_CHLPN/1-1 100.0% 54.4% SYLQVEEL----EKEKISISVA--------AASSLLKSKTSNA------TEKGYSSYQSESS-------------AQTVF 3 PERF_MOUSE/1-20 92.8% 19.7% RTCQLTLNG--LTADEVGDCLNVEAQV-----SIGAQASVSSEYK--ACEEKKKQHKMATSFH-------QTYRERHVEV 4 PERF_HUMAN/1-20 92.8% 16.1% RTCELALEG--LTDNEVEDCLTVEAQV-----NIGIHGSISAEAK--ACEEKKKKHKMTASFH-------QTYRERHSEV 5 CO6_HUMAN/1-205 92.3% 17.7% SSEELKNSG--LTEEEAKHCVRIETKK-----RVLFAKKTKVEHR---CTTNKLSEKHEGSFI-------QGAEKSISLI 6 CO7_HUMAN/1-202 93.3% 15.3% DSEKLKQND--FNSVEEKKCKS---------SGWHFVVKFSSH----GCKELENALKAASGTQ-------NNVLRGEPFI 7 CO9_HUMAN/1-211 92.3% 15.5% DKASMKRKG--VELKDIKRCLGYHLDVSL----AFSEISVGAEFNKDDCVKRGEGRAVNITSE-------NLIDDVVSLI 8 CO8A_HUMAN/1-20 92.3% 17.7% DKAKMESLG--ITSRDITTCFGGSLGIQY-EDKINVGGGLSGD----HCKKFGGGKTERARKA-------MAVEDIISRV 9 CO8B_HUMAN/1-20 92.3% 16.6% NKEAMERGD--YTLNNVHACAKNDFKIGGAIEEVYVSLGVSVG----KCRGILNEIKDRNKRD-------TMVEDLVVLV 10 T22A6.120_At/1- 89.2% 16.6% -QHSSKLQ-----PEDLQKRLKEVADKRF--VEASVVHNTGSE-----RVQASSKVETKEQRL----------RFADTSS 11 MPS1_MOUSE/1-20 96.4% 14.0% -RSSFLLDN--QNSQNTVTASAGI------AFLNIVNFKVETD----YISQTSLTKDYLSNRT-----------NSRVQS 12 SPOC1/1-195 93.8% 14.5% PDASDESK--KNFHEHIETEY-----------SSVLGINGGTR-------DTAQYREYLGRRE------------SKCSV 13 APEX_HELER/1-21 95.9% 9.7% DRSSFVKDASTDMSNSVSVEGN----------YKIFSASLSVDMD--RFSQSASSEKKMGTEYTRYTIGSEEFNEPITIS 14 ASTRO_HUMAN/1-1 87.2% 12.9% PSKKVQQQL-WLQYQKETTELG---------------SKKELK-----SMPFITYLSGLLTAQ----------MLSDDQL 15 KIAA0289_HUMAN/ 87.2% 15.0% PNKQVQRRL-WLEYEDISKGNSPSDESE--------ERERDPK-----VLTFPEYITSLSDSG-------------TKRM 16 TSL_DROME/1-195 88.2% 12.4% SRKNYSMI----KERIKSKGLNGLSKLDL---YNYFAPWFAA-----HLGQIRSASANATVER------WARRKLQYEYY 17 dJ1026E2.C1.1/1 91.3% 14.3% DKQKLGRK----TETTGGASIIGG-------SGNSTAVSLETL----HQLAASYFIDRESTL----------RRLHHIQI 18 IB3089A_HUMAN/1 85.6% 13.5% DKSRLDRK-------SGNATQ-----------------SVEAL----HQLASSYFVDRDGTM----------RRLHEIQI consensus/100% ...t...............t...................ht....................................... consensus/90% ..tp...........p.t.t..................thts........t.........t................... consensus/80% .ptpht........pphptpht................phtst.......t.t...t..tp..................h consensus/70% sppphppp....p.pphptsht.............hthphssp......hpht.thpttsst.............ths.h cov pid 161 . . . 2 . . . . 240 1 CT153_CHLTR/1-1 100.0% 100.0% LGG------TVLPS----------VHDERLDFKDWSESVHLE--PVPIQV-SLQPITNLLVPLHFPNIGAAELSNKRESL 2 CT153_CHLPN/1-1 100.0% 54.4% LGG------TVLPD----------LQQDKLDFKDWSESIPNE--PIPLAI-SVSSITDLIIPELFPSEDAQVLSQKKSAL 3 PERF_MOUSE/1-20 92.8% 19.7% LGG----PLDSTHDLLFG------NQATPEQFSTWTASLPSN--PGLVDY-SLEPLHTLLEEQ----------NPKREAL 4 PERF_HUMAN/1-20 92.8% 16.1% VGG----HHTSINDLLFG------IQAGPEQYSAWVNSLPGS--PGLVDY-TLEPLHVLLDSQ----------DPRREAL 5 CO6_HUMAN/1-205 92.3% 17.7% RGG----RSEYGAALAWE---KGSSGLEEKTFSEWLESVKEN--PAVIDF-ELAPIVDLVRNIP-------CAVTKRNNL 6 CO7_HUMAN/1-202 93.3% 15.3% RGG-GAGFISGLSYLELD-----NPAGNKRRYSAWAESVTNL--PQVIKQ-KLTPLYELVKEVP-------CASVKKLYL 7 CO9_HUMAN/1-211 92.3% 15.5% RGGTRKYAFELKEKLLRG------TVIDVTDFVNWASSINDA--PVLISQ-KLSPIYNLVPVKMK------NAHLKKQNL 8 CO8A_HUMAN/1-20 92.3% 17.7% RGG--SSGWSGGLAQNRS----------TITYRSWGRSLKYN--PVVIDF-EMQPIHEVLRHTSLG-----PLEAKRQNL 9 CO8B_HUMAN/1-20 92.3% 16.6% RGG-ASEHITTLAYQELPT---------ADLMQEWGDAVQYN--PAIIKV-KVEPLYELVTATDFA-----YSSTVRQNM 10 T22A6.120_At/1- 89.2% 16.6% LGS-----YANKEDYVFMCKRRGGNDNRNLMHNEWLQTVQME--PDVISM-SFIPITSLLNGV-----------PGSGFL 11 MPS1_MOUSE/1-20 96.4% 14.0% FGG-----VPFYPG---------------ITLETWQKGITNH--LVAIDR-AGLPLHFFIKPDKLPGLPGPLVKKLSKTV 12 SPOC1/1-195 93.8% 14.5% MGG----HPQLKRSLSRD-------PTNSRLFSQWIRSIGASGTQDVIHV-LADSIYNFLLRSPNP-----EHKEIGDKI 13 APEX_HELER/1-21 95.9% 9.7% LIG----LEEALNDEYWSR--QSEYESSGECPSNWARSTIAT--NILTGLKEYANYRGVVPSSDPDVTVPLTWPDGKYAL 14 ASTRO_HUMAN/1-1 87.2% 12.9% ISG-----VEIRC-EEKGR----CPSTCHLCRRPGKEQLSPT--PVLLEINRVVPLYTLIQDN-----------GTKEAF 15 KIAA0289_HUMAN/ 87.2% 15.0% AAG-----VRMEC-QSKGR----CPSSCPLCHVTSSPDTPAE--PVLLEVTKAAPIYELVTNN-----------QTQRLL 16 TSL_DROME/1-195 88.2% 12.4% VVK-----YVTLLKLHGN----------STLLRSLDSLLGND-AILQLDLKSLKPIFREEPE-------------KESWY 17 dJ1026E2.C1.1/1 91.3% 14.3% ATG----AIKVTETRTGP------LGCSNYDNLDSVSSVLVQ--SPENKV-QLLGLQVLLPEY------------LRERF 18 IB3089A_HUMAN/1 85.6% 13.5% STG----AIKVTETRTGP------LGCNSYDNLDSVSSVLLQ--STESKL-HLQGLQIIFPQY------------LQEKF consensus/100% ..t...................................h.........t...h.sh...................ht..h consensus/90% hsu........h.....................t..tth..t......t..th.sl..hh...............hp..h consensus/80% hsG......phh....h..............h.ph.psl..p..s..lph.ph.slh.ll...............hpp.h consensus/70% huG.....hphhtt..hs.........pthphpsWspol..p..sshlch.phtPlhpll.t.............tcptl cov pid 241 ] 249 1 CT153_CHLTR/1-1 100.0% 100.0% QQAIRVYLK 2 CT153_CHLPN/1-1 100.0% 54.4% GQVILNYLE 3 PERF_MOUSE/1-20 92.8% 19.7% RQAISHYIM 4 PERF_HUMAN/1-20 92.8% 16.1% RRALSQYLT 5 CO6_HUMAN/1-205 92.3% 17.7% RKALQEYAA 6 CO7_HUMAN/1-202 93.3% 15.3% KWALEEYLD 7 CO9_HUMAN/1-211 92.3% 15.5% ERAIEDYIN 8 CO8A_HUMAN/1-20 92.3% 17.7% RRALDQYLM 9 CO8B_HUMAN/1-20 92.3% 16.6% KQALEEFQK 10 T22A6.120_At/1- 89.2% 16.6% SHAINLYLR 11 MPS1_MOUSE/1-20 96.4% 14.0% ETAVRHYYT 12 SPOC1/1-195 93.8% 14.5% QRASRFHSK 13 APEX_HELER/1-21 95.9% 9.7% PEAVTLGDN 14 ASTRO_HUMAN/1-1 87.2% 12.9% KSALMSSYW 15 KIAA0289_HUMAN/ 87.2% 15.0% QEATMSSLW 16 TSL_DROME/1-195 88.2% 12.4% HEVLDNNVK 17 dJ1026E2.C1.1/1 91.3% 14.3% VAAALSYIT 18 IB3089A_HUMAN/1 85.6% 13.5% VQSALSYIM consensus/100% ..s...... consensus/90% .tsh..... consensus/80% tpAh..hh. consensus/70% ppAlppaht